Reporting pharmacoeconomic evaluations

被引：0
|
作者：
C. I. Carswell
J. A. Paladino
机构：
[1] Adis International Limited,
来源：
PharmacoEconomics | 2005年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1073 / 1073
相关论文
共 50 条
  • [41] Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests
    Cleemput, Irina
    van Wilder, Philippe
    Huybrechts, Michel
    Vrijens, France
    VALUE IN HEALTH, 2009, 12 (04) : 441 - 449
  • [42] A REVIEW OF PHARMACOECONOMIC EVALUATIONS OF NEW AND EXISTING TECHNOLOGIES BY THE NATIONAL CENTRE FOR PHARMACOECONOMICS IN IRELAND
    Tilson, L.
    O'Leary, A.
    Usher, C.
    Barry, M.
    VALUE IN HEALTH, 2009, 12 (07) : A250 - A250
  • [43] THE REPORTING QUALITY OF PHARMACOECONOMIC STUDIES BEFORE AND AFTER PUBLICATION OF THE CHEERS CHECKLIST
    Pandey, P.
    Pandey, R.
    Agrawal, V
    Dhagale, P.
    Shah, V
    Gupta, P.
    VALUE IN HEALTH, 2018, 21 : S215 - S215
  • [44] Designing a user-friendly format for reporting an internal pharmacoeconomic analysis
    Basskin, L
    FORMULARY, 1997, 32 (10) : 1067 - &
  • [45] HAS THE PUBLICATION OF CHINA GUIDELINES FOR PHARMACOECONOMIC EVALUATIONS 2020 INFLUENCED THE STUDY QUALITY OF ECONOMIC EVALUATIONS IN CHINA? A SYSTEMATIC REVIEW
    Cao, S.
    Liang, W.
    Liang, C.
    Lin, H.
    Gao, C.
    Yang, L.
    Liu, Y.
    Suo, Y.
    Liu, K.
    Chen, Y.
    Jin, X.
    VALUE IN HEALTH, 2023, 26 (12) : S557 - S557
  • [46] DEVELOPMENT OF A CHECK LIST FOR QUALITY ASSESSMENT OF PHARMACOECONOMIC EVALUATIONS SUBMITTED FOR REIMBURSEMENT IN TAIWAN
    Wu, G. H. M.
    Liao, C. H.
    Shau, W. Y.
    Lo, P. C.
    Pwu, R. F.
    VALUE IN HEALTH, 2012, 15 (07) : A608 - A608
  • [47] Guidelines for Economic Evaluations in Italy: Recommendations from The Italian Group of Pharmacoeconomic Studies
    Stefano Capri
    Adriana Ceci
    Lorenzo Terranova
    Franco Merlo
    Lorenzo Mantovani
    Drug information journal : DIJ / Drug Information Association, 2001, 35 (1): : 189 - 201
  • [48] Guidelines for economic evaluations in Italy: Recommendations from the Italian Group of Pharmacoeconomic Studies
    Capri, S
    Ceci, A
    Terranova, L
    Merlo, F
    Mantovani, L
    DRUG INFORMATION JOURNAL, 2001, 35 (01): : 189 - 201
  • [49] Transparent reporting of evaluations with nonrandomized designs (TREND)
    Vlahov, D
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2004, 81 (02): : 163 - 164
  • [50] RAMESES II reporting standards for realist evaluations
    Geoff Wong
    Gill Westhorp
    Ana Manzano
    Joanne Greenhalgh
    Justin Jagosh
    Trish Greenhalgh
    BMC Medicine, 14
12345